Rapid swab-based point-of-care antigen testing assay proof-of-concept for the detection of SARS-CoV-2

新冠肺炎疫情对英国数百万家庭的生计产生了直接影响。不幸的是，对我们日常生活设置的限制将持续下去，直到冠状病毒检测被广泛采用。自适应诊断公司的使命是创造一种廉价、快速和准确的基于唾液的冠状病毒检测方法，所有医护人员都可以使用它来快速筛查和识别疾病阳性或阴性的患者。我们将通过使用我们正在开发的一种新型生物传感器检测病毒表面存在的一种独特的分子来做到这一点。这将为我们测试的用户提供一个简单而可靠的视觉读数，如果被测试的患者病毒呈阳性的话。通过这样做，我们希望帮助造福世界各地的人们。我们正在开发的技术也可以应用于其他疾病，与我们整体业务战略的其他方面协同，确保我们为抗击未来的任何疫情做好最好的准备，并为诊断带来适应性。我们的目标是：*提高人们筛查新冠肺炎等传染病的速度和便利性*减少一线医护人员和中央实验室的风险和压力*为诊断市场上现有的筛查方法提供一种新的替代方法

The COVID-19 pandemic has had a direct effect on the livelihoods of millions here at home in the UK. Unfortunately, the restrictions set on our daily lives will persist until a coronavirus test is widely adopted. Adaptive Diagnostics have made it our mission to create a cheap, rapid and accurate saliva-based coronavirus test that can be used by all healthcare workers to quickly screen and identify those patients who are positive or negative for the disease. We will do this by detecting a distinct molecule present on the virus's surface with a novel biosensor that we are developing. This will give the user of our test a simple and reliable visual readout if the tested patient is positive for the virus. In doing so we hope to help benefit people everywhere. The technology we are developing can also be applied to other diseases, synergising with other aspects of our overall business strategy, ensuring we are best prepared to fight any future outbreaks, and bringing adaptivity to diagnostics. We aim to: * Increase the rate and ease at which people can be screened for infectious disease like COVID-19 * Reduce the risks and strains on frontline healthcare staff and centralised laboratories * Provide a novel and alternative screening method to those that are currently available in the diagnostic market